Why Viking Therapeutics Stock Bumped 3% Higher Today [Yahoo! Finance]

Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
10 stocks we like better than Viking Therapeutics › A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics (NASDAQ: VKTX) stock on Friday, which closed the trading session 3% higher. That figure was well higher than the 0.7% increase of the benchmark S&P 500 index. That rival is Novo Nordisk , which announced that its current CEO Lars Jørgensen is to vacate his position This is the Denmark-based pharmaceutical company that vaulted to prominence earlier this decade when its Wegovy became the first GLP-1 drug approved for obesity by the U.S. Food and Drug Administration (FDA). The European company is a potential competitor because, similarly, Viking has gained a degree of fame with its VK2735, an investigational weight-loss treatment. The medicine performed exceedingly well in phase 2 clinical testing, and hopes are high that it will not only win FDA approval ultimately, but will be a hot item in a hot market when commercialized
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- 2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics (VKTX) Rises on Expected Developments [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note [Yahoo! Finance]Yahoo! Finance
- Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)? [Yahoo! Finance]Yahoo! Finance
- 1 Stock Down 34% This Year to Buy and Hold [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 4/23/25 - Miss
VKTX
Sec Filings
- 5/27/25 - Form 8-K
- 5/12/25 - Form SCHEDULE
- 4/24/25 - Form 10-Q
- VKTX's page on the SEC website